rs267608436

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP5BS2

This summary comes from the ClinGen Evidence Repository: The p.Arg65Gln variant in CDKL5 is present in 2 female and 1 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg65Gln variant is observed in at least 2 unaffected individuals (internal database) (BS2). The p.Arg65Gln variant is found in 2 patients with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Arg65Gln variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP5). LINK:https://erepo.genome.network/evrepo/ui/classification/CA170462/MONDO:0100039/034

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000016 ( 0 hom. 8 hem. )

Consequence

CDKL5
NM_001323289.2 missense

Scores

9
2
6

Clinical Significance

Likely benign reviewed by expert panel B:6

Conservation

PhyloP100: 10.0

Publications

6 publications found
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
CDKL5 Gene-Disease associations (from GenCC):
  • CDKL5 disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • precocious puberty
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP5
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKL5NM_001323289.2 linkc.194G>A p.Arg65Gln missense_variant Exon 5 of 18 ENST00000623535.2 NP_001310218.1 O76039-2
CDKL5NM_001037343.2 linkc.194G>A p.Arg65Gln missense_variant Exon 6 of 22 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.194G>A p.Arg65Gln missense_variant Exon 5 of 21 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKL5ENST00000623535.2 linkc.194G>A p.Arg65Gln missense_variant Exon 5 of 18 1 NM_001323289.2 ENSP00000485244.1 O76039-2

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111779
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000164
AC:
3
AN:
182997
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000245
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000165
AC:
18
AN:
1093207
Hom.:
0
Cov.:
28
AF XY:
0.0000223
AC XY:
8
AN XY:
358913
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26282
American (AMR)
AF:
0.0000284
AC:
1
AN:
35165
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19334
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54021
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40511
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4114
European-Non Finnish (NFE)
AF:
0.0000203
AC:
17
AN:
837697
Other (OTH)
AF:
0.00
AC:
0
AN:
45929
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111779
Hom.:
0
Cov.:
23
AF XY:
0.0000294
AC XY:
1
AN XY:
34005
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30776
American (AMR)
AF:
0.00
AC:
0
AN:
10514
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3556
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2686
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6001
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.0000376
AC:
2
AN:
53161
Other (OTH)
AF:
0.00
AC:
0
AN:
1511
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.0000546
EpiControl
AF:
0.000119

ClinVar

Significance: Likely benign
Submissions summary: Benign:6
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

CDKL5 disorder Benign:2
Aug 23, 2023
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance:Likely benign
Review Status:reviewed by expert panel
Collection Method:curation

The p.Arg65Gln variant in CDKL5 is present in 2 female and 1 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg65Gln variant is observed in at least 2 unaffected individuals (internal database) (BS2). The p.Arg65Gln variant is found in 2 patients with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Arg65Gln variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP5). -

Jul 02, 2024
Centre for Population Genomics, CPG
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in population databases (gnomAD , Turkish Variome) is between 0.008% and 0.03% (BS1). The variant is observed in at least 2 individuals with no features of CDKL5 disorder (BS2). PubMed: 17993579 Variation ID: 143789 -

not specified Benign:1
May 09, 2014
RettBASE
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

Reported in paper as c.193C>A, but chromatogram shows c.194G>A; found in unaffected male family member; however, In silico prediction: SIFT = deleterious, MutationTaster = disease-causing, PolyPhen2 = probably damaging, AlignGVGD = pathogenic (C35) -

not provided Benign:1
May 05, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 17993579) -

CDKL5-related disorder Benign:1
Apr 08, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
May 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.26
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.20
T;T;.;T;.;.;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
.;D;D;D;D;D;D
M_CAP
Pathogenic
0.79
D
MetaRNN
Pathogenic
0.97
D;D;D;D;D;D;D
MetaSVM
Benign
-0.36
T
MutationAssessor
Benign
0.41
N;.;.;N;.;.;N
PhyloP100
10
PrimateAI
Pathogenic
0.90
D
PROVEAN
Uncertain
-3.9
D;.;.;D;.;.;.
REVEL
Pathogenic
0.68
Sift
Benign
0.031
D;.;.;D;.;.;.
Sift4G
Benign
0.078
T;.;.;T;T;D;D
Polyphen
1.0
D;.;.;D;.;.;.
Vest4
0.91
MutPred
0.86
Loss of MoRF binding (P = 0.0201);Loss of MoRF binding (P = 0.0201);Loss of MoRF binding (P = 0.0201);Loss of MoRF binding (P = 0.0201);Loss of MoRF binding (P = 0.0201);Loss of MoRF binding (P = 0.0201);Loss of MoRF binding (P = 0.0201);
MVP
0.92
MPC
2.4
ClinPred
0.80
D
GERP RS
5.7
Varity_R
0.86
gMVP
0.93
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267608436; hg19: chrX-18593522; COSMIC: COSV66111634; COSMIC: COSV66111634; API